ISHL12 - Our commitment to a safe event for everybody during the pandemic
 Cologne, December 2021 
 Dear colleagues,  
 We are committed to a safe ISHL12 during these challenging times. In order to ensure the usual interactive participation of all interested hematologists worldwide, the ISHL team is currently planning a hybrid event from October 22 to 24, 2022.  
 We know you are eager to participate in-person, to network with colleagues, discuss the latest scientific advances and groundbreaking research presentations and experience the symposia, exhibit and posters. As the safety of our attendees is our top priority, proof of being fully vaccinated against COVID-19 will be required for in-person participation. Further, detailed specifications will be provided in due time before our congress. Depending on the situation in October 2022 and requirements by German regulations, additional COVID-19 testing requirements might apply.  
 However, we also know that some of you will hesitate or not be able to attend in-person. If you fall into that group, be assured that we also want you to have the best possible ISHL experience. Therefore, a hybrid event with the possibility of both in-person and online attendance is in our view the best way forward.  
 ISHL12 will provide a comprehensive overview on the latest advances in biology, clinical research, diagnostics and treatment of Hodgkin Lymphoma. A main focus will be on older and frail patients and on patients with early stages. Several workshops, interactive case discussions and satellite symposia will complement the program.  
 For more information, please visit our homepage or contact our organizational team at  
 Take care and stay safe!  
Andreas Engert, MD,
Symposium and GHSG Chairman
Sven Borchmann, MD,
Symposium Secretary
Paul J. Bröckelmann, MD,
Symposium Secretary
Dennis A. Eichenauer, MD,
Symposium Secretary
 Please do not reply directly to this message. If you would like more information on the 12ᵗʰ International Symposium on Hogkin Lymphoma, or have additional questions please contact Gabriele Hanke (  
 Please add to your address book to prevent spam filters from blocking these E-Mails.  
 12ᵗʰ International Symposium on Hodgkin Lymphoma
Prof. Dr. med. Andreas Engert
Professor for Internal Medicine, Hematology & Oncology
German Hodgkin Study Group (GHSG) | Gleueler Str. 269-273 | 50937 Cologne
 Tel. +49 (0)221-478 5933
Fax +49 (0)221-478 3778
 For more information please click here.